From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells
出版年份 2017 全文链接
标题
From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells
作者
关键词
-
出版物
TOXICOLOGICAL SCIENCES
Volume 157, Issue 2, Pages 451-464
出版商
Oxford University Press (OUP)
发表日期
2017-03-24
DOI
10.1093/toxsci/kfx062
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury
- (2016) Xi Qiu et al. MOLECULAR PHARMACEUTICS
- Update on pulmonary arterial hypertension pharmacotherapy
- (2016) Arash Velayati et al. POSTGRADUATE MEDICINE
- Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs
- (2016) Ahmad Sharanek et al. Scientific Reports
- Pharmacokinetic and pharmacodynamic evaluation of macitentan, a novel endothelin receptor antagonist for the treatment of pulmonary arterial hypertension
- (2015) Patricia N Sidharta et al. Expert Opinion on Drug Metabolism & Toxicology
- Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes
- (2015) Pamela Bachour-El Azzi et al. TOXICOLOGICAL SCIENCES
- Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes
- (2015) Ahmad Sharanek et al. TOXICOLOGICAL SCIENCES
- Pharmacokinetic–Pharmacodynamic Relationships of Macitentan, a New Endothelin Receptor Antagonist, After Multiple Dosing in Healthy Korean Subjects
- (2014) Li Young Ahn et al. American Journal of Cardiovascular Drugs
- Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension
- (2014) Marie-Camille Chaumais et al. American Journal of Cardiovascular Drugs
- Macitentan for the treatment of pulmonary arterial hypertension
- (2014) Namita Sood EXPERT OPINION ON PHARMACOTHERAPY
- Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients
- (2014) Gérald Simonneau et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Evaluation of the Endothelin Receptor Antagonists Ambrisentan, Bosentan, Macitentan, and Sitaxsentan as Hepatobiliary Transporter Inhibitors and Substrates in Sandwich-Cultured Human Hepatocytes
- (2014) Eve-Irene Lepist et al. PLoS One
- Different Dose-Dependent Mechanisms Are Involved in Early Cyclosporine A-Induced Cholestatic Effects in HepaRG Cells
- (2014) Ahmad Sharanek et al. TOXICOLOGICAL SCIENCES
- Bioactivation of Sitaxentan in Liver Microsomes, Hepatocytes, and Expressed Human P450s with Characterization of the Glutathione Conjugate by Liquid Chromatography Tandem Mass Spectrometry
- (2013) John C. L. Erve et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension
- (2013) Yoshihiro Fukumoto et al. CIRCULATION JOURNAL
- Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
- (2013) Tomás Pulido et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Multifactorial Approach to Hepatobiliary Transporter Assessment Enables Improved Therapeutic Compound Development
- (2013) Ryan E. Morgan et al. TOXICOLOGICAL SCIENCES
- Early Identification of Clinically Relevant Drug Interactions With the Human Bile Salt Export Pump (BSEP/ABCB11)
- (2013) Jenny M. Pedersen et al. TOXICOLOGICAL SCIENCES
- Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells
- (2012) Johanna Weiss et al. BIOCHEMICAL PHARMACOLOGY
- Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells
- (2012) Sébastien Anthérieu et al. HEPATOLOGY
- The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist
- (2012) Martin H. Bolli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension
- (2012) Ori Ben-Yehuda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension
- (2012) Shinichi Takatsuki et al. PEDIATRIC PULMONOLOGY
- Slow Receptor Dissociation Kinetics Differentiate Macitentan from Other Endothelin Receptor Antagonists in Pulmonary Arterial Smooth Muscle Cells
- (2012) John Gatfield et al. PLoS One
- An overview of the preclinical toxicity and potential carcinogenicity of sitaxentan (Thelin®), a potent endothelin receptor antagonist developed for pulmonary arterial hypertension
- (2012) Keith Owen et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans
- (2012) Shirin Bruderer et al. XENOBIOTICA
- Pulmonary Arterial Hypertension
- (2011) Vallerie V. McLaughlin et al. CURRENT PROBLEMS IN CARDIOLOGY
- Macitentan: entry-into-humans study with a new endothelin receptor antagonist
- (2011) Patricia N. Sidharta et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Liver toxicity of sitaxentan in pulmonary arterial hypertension
- (2011) N. Galie et al. EUROPEAN RESPIRATORY JOURNAL
- Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye
- (2011) K. Pernelle et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytesThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.
- (2010) J. Craig Hartman et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Bosentan
- (2009) Sohita Dhillon et al. American Journal of Cardiovascular Drugs
- The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjects
- (2009) Fiona Stavros et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
- (2009) A. Lavelle et al. EUROPEAN RESPIRATORY JOURNAL
- Ambrisentan
- (2008) Jamie D Croxtall et al. DRUGS
- Endothelin receptor antagonists in pulmonary arterial hypertension
- (2008) J. Dupuis et al. EUROPEAN RESPIRATORY JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started